Tumor-associated astrocytes augment cholesterol synthesis to support glioblastoma growth through alternatively spliced Quaking (QKI) isoforms
Neuro-Oncology · 2026
DOI: 10.1093/neuonc/noag030 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuro-Oncology, 2026. Verfasst von Runxin Wu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: Astrocytes, Glioblastoma, Brain Neoplasms, Cholesterol. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Guangdong Province Regional Joint Fund.
Abstract (Originalsprache)
Background
Glioblastoma (GBM) is a highly aggressive brain tumor with limited treatment options. Tumor-associated astrocytes (TAAs) are crucial components of the GBM microenvironment, yet the contribution of alternative splicing (AS) in TAAs to tumor progression remains unclear.
Methods
Transcriptomic and molecular analyses of GBM-associated astrocytes revealed a GBM-induced isoform switch in the RNA-binding protein Quaking (QKI) from the QKI-6 isoform to QKI-5 isoform. The biological role of QKI-5 was examined through gain- and loss-of-function approaches in human astrocytes and co-culture systems with patient-derived glioma stem-like cells (GSCs). In vitro proliferation and sphere-formation assays, along with in vivo orthotopic xenograft models, were used to evaluate tumor growth. Immunoprecipitation and AlphaFold3 structural prediction were performed to investigate the mechanistic interaction between QKI-5 and sterol regulatory element-binding protein 2 (SREBP2).
Results
GBM-induced QKI-5 interacts with SREBP2 to transcriptionally activate cholesterol metabolic enzymes, enhancing astrocyte-derived cholesterol production and promoting GBM growth. Knockdown of QKI-5 or inhibitors for SREBP2-driven signaling suppressed astrocyte-mediated tumor-supportive effects in vitro and in vivo.
Conclusion
QKI-5 drives astrocytic metabolic reprogramming via the QKI-5–SREBP2 axis, fostering a cholesterol-rich tumor microenvironment that supports GBM progression. Targeting this pathway offers a potential therapeutic strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.
- The Ken & Ruth Davee Department of Neurology, The Lou and Jean Malnati Brain Tumor Institute, The Robert H. Lurie Comprehensive Cancer Center, Simpson Querrey Institute for Epigenetics, Northwestern University Feinberg…
- Department of Pathology, The Lou and Jean Malnati Brain Tumor Institute, The Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
- Department of Neurological Surgery, The Lou and Jean Malnati Brain Tumor Institute, The Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
ORCID-Profile: Bo Hu, Shi-Yuan Cheng
Förderung
- Guangdong Province Regional Joint Fund
Zitieren
APA
Wu, R., Yu, X., Song, X., He, Q., Walker, M., Sisbarro, D., Horbinski, C., Tiek, D., Hu, B., Zhang, N., & Cheng, S. Y. (2026). Tumor-associated astrocytes augment cholesterol synthesis to support glioblastoma growth through alternatively spliced Quaking (QKI) isoforms. Neuro-Oncology. https://doi.org/10.1093/neuonc/noag030
Vancouver
Wu R, Yu X, Song X, He Q, Walker M, Sisbarro D, et al. Tumor-associated astrocytes augment cholesterol synthesis to support glioblastoma growth through alternatively spliced Quaking (QKI) isoforms. Neuro-Oncology. 2026. doi:10.1093/neuonc/noag030
BibTeX
@article{Wu2026,
author = {Wu, Runxin and Yu, Xiaozhou and Song, Xiao and He, Qiu and Walker, Maya and Sisbarro, Derek and Horbinski, Craig and Tiek, Deanna and Hu, Bo and Zhang, Nu and Cheng, Shi-Yuan},
title = {Tumor-associated astrocytes augment cholesterol synthesis to support glioblastoma growth through alternatively spliced Quaking (QKI) isoforms},
journal = {Neuro-Oncology},
year = {2026},
doi = {10.1093/neuonc/noag030}
}
EUVIMED